Competition/Antitrust

About

Provided by Axinn

Axinn has more than 70 full time antitrust lawyers working on M&A, litigation, criminal and conduct investigations. We have been global lead on mergers worth close to half a trillion dollars, including: Dell’s $67 billion acquisition of EMC; Thermo Fisher’s $13.6 billion acquisition of Life Technologies and $12.5 billion tender offer of Qiagen; Ball Corporation’s $6 billion acquisition of Rexam; Johnson Controls’ $2 billion sale of Scott Safety to 3M; McKesson’s $3.4 billion joint venture with Change Healthcare; and Google’s most complex deals, including Motorola Mobility and ITA Software. Axinn has extensive experience in major trials and class actions, including the highly publicized ad tech business litigations (for Google); multiple major treble-damage class action litigations and regulatory investigations (for Tyson Foods); a patent infringement and antitrust litigation and the Generic Drugs MDL (for Alvogen); and In Re Blue Cross antitrust litigation (for IBC). The firm has litigated six merger cases brought by government agencies (winning five) and has a strong presence and track record in ongoing DOJ criminal antitrust matters and related litigation. The group has extensive experience with antitrust and IP issues, including Google’s settlement with the FTC on standard essential patents. Axinn has deep contacts with the staff and front offices of the FTC and the DOJ, and employs lawyers with more than 60 years of combined government antitrust experience.